Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma
Author: Steven F. Powell, Miroslaw Mazurczak, Elie G. Dib, et al.
Year Published: 2022
Media Outlet: Investigational New Drugs
Open Access? No
Matrix: Plasma and Serum
Biological Themes: Other
Product(s): Global Discovery Panel
Cited in over 3,000 publications, we help scientists and manufacturers gain greater insight into their studies through metabolomics.
GET STARTED
Talk with an expert
Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.
Find us on:
